Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by FredTheVoiceon Sep 13, 2020 8:30pm

172 Views

Post# 31550757

RE:RE:RE:Off Label?

I think your wrong a little on that one: the news is not out yet. But the company is saying: we have everything following our exchanges with the regulators to know that its a go.

In a month or two, yes, when the FDA and EMA will say GO. That will be the news.

GLTY. Hope you can be patient for another two months.....

FTV.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?